Where Is the “Optimal” Fontan Hemodynamics?

Fontan circulation is generally characterized by high central venous pressure, low cardiac output, and slightly low arterial oxygen saturation, and it is quite different from normal biventricular physiology. Therefore, when a patient with congenital heart disease is selected as a candidate for this type of circulation, the ultimate goals of therapy consist of 2 components. One is a smooth adjustment to the new circulation, and the other is long-term circulatory stabilization after adjustment. When either of these goals is not achieved, the patient is categorized as having “failed” Fontan circulation, and the prognosis is dismal. For the first goal of smooth adjustment, a lot of effort has been made to establish criteria for patient selection and intensive management immediately after the Fontan operation. For the second goal of long-term circulatory stabilization, there is limited evidence of successful strategies for long-term hemodynamic stabilization. Furthermore, there have been no data on optimal hemodynamics in Fontan circulation that could be used as a reference for patient management. Although small clinical trials and case reports are available, the results cannot be generalized to the majority of Fontan survivors. We recently reported the clinical and hemodynamic characteristics of early and late failing Fontan survivors and their association with all-cause mortality. This knowledge could provide insight into the complex Fontan pathophysiology and might help establish a management strategy for long-term hemodynamic stabilization.

[1]  Mark J Schuuring,et al.  Impact of bosentan on exercise capacity in adults after the Fontan procedure: a randomized controlled trial , 2013, European journal of heart failure.

[2]  P. Kamath,et al.  Hepatocellular carcinoma after the Fontan procedure. , 2013, The New England journal of medicine.

[3]  T. Levine,et al.  Regional blood flow supply and demand in heart failure. , 1990, American heart journal.

[4]  P. Poirier,et al.  Impact of exercise training on muscle function and ergoreflex in Fontan patients: a pilot study. , 2006, International journal of cardiology.

[5]  J. Tam,et al.  Resolution of protein-losing enteropathy with low-molecular weight heparin in an adult patient with Fontan palliation. , 2007, The Annals of thoracic surgery.

[6]  D. Ivy,et al.  Evidence of pulmonary vascular disease after heart transplantation for Fontan circulation failure. , 2004, The Journal of thoracic and cardiovascular surgery.

[7]  W. Book,et al.  Clinical Phenotypes of Fontan Failure: Implications for Management. , 2016, Congenital heart disease.

[8]  A. Hager,et al.  Effect of sildenafil on haemodynamic response to exercise and exercise capacity in Fontan patients. , 2008, European heart journal.

[9]  V. Fuster,et al.  Contemporary medical management of systolic heart failure. , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[10]  R. Groszmann,et al.  Phosphorylation of eNOS initiates excessive NO production in early phases of portal hypertension. , 2002, American journal of physiology. Heart and circulatory physiology.

[11]  K. Schumacher,et al.  Dopamine as a potential rescue therapy for refractory protein‐losing enteropathy in Fontan‐palliated patients , 2017, Pediatric transplantation.

[12]  G. Kemp,et al.  Resistance training improves cardiac output, exercise capacity and tolerance to positive airway pressure in Fontan physiology. , 2012, International journal of cardiology.

[13]  S. Yazaki,et al.  Haemodynamic characteristics before and after the onset of protein losing enteropathy in patients after the Fontan operation. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[14]  D. Driscoll,et al.  Prevalence and outcome of thrombotic and embolic complications in adults after Fontan operation , 2017, American heart journal.

[15]  M. Ono,et al.  Arrhythmias After Fontan Operation with Intra-atrial Lateral Tunnel Versus Extra-cardiac Conduit: A Systematic Review and Meta-analysis , 2017, Pediatric Cardiology.

[16]  J. Rychik,et al.  Lean mass deficits, vitamin D status and exercise capacity in children and young adults after Fontan palliation , 2014, Heart.

[17]  T. Yagihara,et al.  High prevalence of abnormal glucose metabolism in young adult patients with complex congenital heart disease. , 2009, American heart journal.

[18]  Dionne A. Graham,et al.  Effect of inhaled iloprost on the exercise function of Fontan patients: a demonstration of concept. , 2013, International journal of cardiology.

[19]  N. S. Gaither,et al.  Development of pulmonary arteriovenous malformations after modified Fontan operations. , 1989, The Journal of thoracic and cardiovascular surgery.

[20]  H. Ohuchi,et al.  Restrictive Ventilatory Impairment and Arterial Oxygenation Characterize Rest and Exercise Ventilation in Patients After Fontan Operation , 2004, Pediatric Cardiology.

[21]  G. Stellin,et al.  Effects of aerobic exercise training in children after the Fontan operation. , 2005, The American journal of cardiology.

[22]  D. Driscoll,et al.  The use of oral budesonide in adolescents and adults with protein-losing enteropathy after the Fontan operation. , 2011, The Annals of thoracic surgery.

[23]  L. Bergamasco,et al.  Endothelin inhibitors lower pulmonary vascular resistance and improve functional capacity in patients with Fontan circulation , 2017, The Journal of thoracic and cardiovascular surgery.

[24]  H. Drexler Reduced exercise tolerance in chronic heart failure and its relationship to neurohumoral factors. , 1991, European heart journal.

[25]  M. Aoki,et al.  Successful Fontan completion after cardiac resynchronization therapy. , 2012, Circulation.

[26]  Y. D'udekem,et al.  Long-term outcomes after first-onset arrhythmia in Fontan physiology. , 2016, The Journal of thoracic and cardiovascular surgery.

[27]  Dionne A. Graham,et al.  MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery , 2013, Heart.

[28]  J. Myers,et al.  Prospective, Longitudinal Study of Plastic Bronchitis Cast Pathology and Responsiveness to Tissue Plasminogen Activator , 2011, Pediatric Cardiology.

[29]  C R Benedict,et al.  Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators. , 1996, Circulation.

[30]  S. Apostolopoulou,et al.  Bosentan induces clinical, exercise and hemodynamic improvement in a pre-transplant patient with plastic bronchitis after Fontan operation. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[31]  K. Sørensen,et al.  Bosentan Improves Exercise Capacity in Adolescents and Adults After Fontan Operation: The TEMPO (Treatment With Endothelin Receptor Antagonist in Fontan Patients, a Randomized, Placebo-Controlled, Double-Blind Study Measuring Peak Oxygen Consumption) Study , 2014, Circulation.

[32]  Emir Veledar,et al.  Hemodynamic phenotype of the failing Fontan in an adult population. , 2013, The American journal of cardiology.

[33]  D. Driscoll,et al.  Sudden cardiac death and late arrhythmias after the Fontan operation , 2017, Congenital heart disease.

[34]  M. Sugimoto,et al.  Effectiveness of High-dose Spironolactone Therapy in a Patient with Recurrent Protein-losing Enteropathy after the Fontan Procedure. , 2016, Internal medicine.

[35]  M. Mizuno,et al.  Prevalence and predictors of haemostatic complications in 412 Fontan patients: their relation to anticoagulation and haemodynamics. , 2015, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[36]  J. Rychik,et al.  Percutaneous Lymphatic Embolization of Abnormal Pulmonary Lymphatic Flow as Treatment of Plastic Bronchitis in Patients With Congenital Heart Disease , 2016, Circulation.

[37]  R. D. de Winter,et al.  Percutaneous tricuspid valve implantation in a Fontan patient with congestive heart failure and protein-losing enteropathy. , 2011, Circulation. Cardiovascular interventions.

[38]  M. Griselli,et al.  Management of the failing Fontan. , 2015, Seminars in thoracic and cardiovascular surgery. Pediatric cardiac surgery annual.

[39]  S. Solomon,et al.  Survival with cardiac-resynchronization therapy in mild heart failure. , 2014, The New England journal of medicine.

[40]  H. Uemura,et al.  Influence of ventricular morphology on aerobic exercise capacity in patients after the Fontan operation. , 2001, Journal of the American College of Cardiology.

[41]  A. Redington,et al.  Atrioventricular valve repair in patients with functional single-ventricle physiology: impact of ventricular and valve function and morphology on survival and reintervention. , 2011, The Journal of thoracic and cardiovascular surgery.

[42]  P. Kamath,et al.  Liver Disease in Patients After the Fontan Operation. , 2016, The American journal of cardiology.

[43]  E. Bacha,et al.  Effects of lack of pulsatility on pulmonary endothelial function in the Fontan circulation. , 2013, The Journal of thoracic and cardiovascular surgery.

[44]  M. Jacobs,et al.  Management of the failing Fontan circulation , 2012, Heart.

[45]  K. Sharkey,et al.  Hyperdynamic circulation in portal‐hypertensive rats is dependent on central c‐fos gene expression , 2002, Hepatology.

[46]  H. Ohuchi,et al.  Long-term serial aerobic exercise capacity and hemodynamic properties in clinically and hemodynamically good, "excellent", Fontan survivors. , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[47]  H. Ohuchi Adult patients with Fontan circulation: What we know and how to manage adults with Fontan circulation? , 2016, Journal of cardiology.

[48]  John K. Triedman,et al.  Long-Term Survival, Modes of Death, and Predictors of Mortality in Patients With Fontan Surgery , 2008, Circulation.

[49]  J. Rychik,et al.  Effect of Fontan-Associated Morbidities on Survival With Intact Fontan Circulation. , 2017, The American journal of cardiology.

[50]  Andrew H Van Bergen,et al.  Long-term treatment of plastic bronchitis with aerosolized tissue plasminogen activator in a Fontan patient , 2005, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[51]  F. Wong Cirrhotic cardiomyopathy , 2009, Hepatology international.

[52]  P. Schumacker,et al.  Hypoxia-induced changes in pulmonary and systemic vascular resistance: Where is the O2 sensor? , 2010, Respiratory Physiology & Neurobiology.

[53]  H. Matsuda,et al.  Heart transplantation for adults with congenital heart disease: current status and future prospects , 2017, General Thoracic and Cardiovascular Surgery.

[54]  Orhan Uzun,et al.  Resolution of protein-losing enteropathy and normalization of mesenteric Doppler flow with sildenafil after Fontan. , 2006, The Annals of thoracic surgery.

[55]  M. Mizuno,et al.  Comparison of prognostic variables in children and adults with Fontan circulation. , 2014, International journal of cardiology.

[56]  J. Rychik,et al.  Deficits in bone density and structure in children and young adults following Fontan palliation. , 2015, Bone.

[57]  J. Fragata,et al.  Thoracic Duct Decompression for Protein-Losing Enteropathy in Failing Fontan Circulation. , 2016, The Annals of thoracic surgery.

[58]  Makoto Mori,et al.  Catheter-measured Hemodynamics of Adult Fontan Circulation: Associations with Adverse Event and End-organ Dysfunctions. , 2016, Congenital heart disease.

[59]  R. Groszmann,et al.  The hyperdynamic circulation of chronic liver diseases: From the patient to the molecule , 2006, Hepatology.

[60]  F. Fontan,et al.  Surgical repair of tricuspid atresia , 1971, Thorax.

[61]  I. Shiraishi,et al.  Renal resistive index reflects Fontan pathophysiology and predicts mortality , 2017, Heart.

[62]  Rebecca G. Wells,et al.  The Precarious State of the Liver After a Fontan Operation: Summary of a Multidisciplinary Symposium , 2012, Pediatric Cardiology.

[63]  M. Heinemann,et al.  Incidence and impact of systemic venous collateral development after Glenn and Fontan procedures. , 2001, The Thoracic and cardiovascular surgeon.

[64]  L. Hudsmith,et al.  Prevalence of atrial tachyarrhythmia in adults after Fontan operation , 2015, Heart.

[65]  C. Brizard,et al.  The Fontan Procedure: Contemporary Techniques Have Improved Long-Term Outcomes , 2007, Circulation.

[66]  D. Schranz,et al.  Aortopulmonary Collateral Flow Is Related to Pulmonary Artery Size and Affects Ventricular Dimensions in Patients after the Fontan Procedure , 2013, PloS one.

[67]  I. Shiraishi,et al.  Hemodynamic determinants of mortality after Fontan operation , 2017, American heart journal.

[68]  K. Dimopoulos,et al.  Survival Prospects and Circumstances of Death in Contemporary Adult Congenital Heart Disease Patients Under Follow-Up at a Large Tertiary Centre , 2015, Circulation.

[69]  D. Driscoll,et al.  Clinical outcomes and improved survival in patients with protein-losing enteropathy after the Fontan operation. , 2014, Journal of the American College of Cardiology.

[70]  N. Méndez-Sánchez,et al.   Hepatorenal syndrome: Current concepts related to diagnosis and management. , 2016, Annals of hepatology.

[71]  I. Konstantinov,et al.  Meta-Analysis of the Effectiveness of Heart Transplantation in Patients With a Failing Fontan. , 2017, The American journal of cardiology.

[72]  Y. D'udekem,et al.  Common atrioventricular valve failure during single ventricle palliation† , 2017, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[73]  H. Heidbuchel,et al.  Sildenafil Improves Exercise Hemodynamics in Fontan Patients , 2014, Circulation. Cardiovascular imaging.

[74]  J. Rychik,et al.  Impact of Oral Sildenafil on Exercise Performance in Children and Young Adults After the Fontan Operation: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial , 2011, Circulation.

[75]  Makoto Mori,et al.  Beyond a Broken Heart: Circulatory Dysfunction in the Failing Fontan , 2014, Pediatric Cardiology.

[76]  H. Ichikawa,et al.  Impact of the evolution of the Fontan operation on early and late mortality: a single-center experience of 405 patients over 3 decades. , 2011, The Annals of thoracic surgery.